LGM

Logos Global Management Portfolio holdings

AUM $1.5B
1-Year Est. Return 197.64%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+197.64%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.5B
AUM Growth
+$488M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
80
New
Increased
Reduced
Closed

Top Buys

1
+$46.6M
2
+$28M
3
+$27.9M
4
IMVT icon
Immunovant
IMVT
+$24.5M
5
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$20.6M

Top Sells

1
+$57M
2
+$47.5M
3
+$21.8M
4
VSTM icon
Verastem
VSTM
+$20.9M
5
PTGX icon
Protagonist Therapeutics
PTGX
+$19.9M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRVI icon
26
Trevi Therapeutics
TRVI
$1.91B
$19.4M 1.29%
1,550,000
-650,000
CYTK icon
27
Cytokinetics
CYTK
$8.17B
$19.1M 1.27%
+300,000
MIRM icon
28
Mirum Pharmaceuticals
MIRM
$5.83B
$17.8M 1.18%
+225,000
QURE icon
29
uniQure
QURE
$1.09B
$16.2M 1.08%
675,000
+375,000
NAMS icon
30
NewAmsterdam Pharma
NAMS
$3.94B
$15.8M 1.05%
+450,000
KNSA icon
31
Kiniksa Pharmaceuticals
KNSA
$3.46B
$14.4M 0.96%
+350,000
SLNO icon
32
Soleno Therapeutics
SLNO
$2.72B
$13.9M 0.93%
+300,000
JANX icon
33
Janux Therapeutics
JANX
$940M
$13.8M 0.92%
1,000,000
+65,000
NERV icon
34
Minerva Neurosciences
NERV
$274M
$13.3M 0.89%
+3,311,000
VSTM icon
35
Verastem
VSTM
$577M
$13.1M 0.87%
1,700,000
-2,350,000
DNTH icon
36
Dianthus Therapeutics
DNTH
$5.06B
$13M 0.87%
315,000
+115,000
AMLX icon
37
Amylyx Pharmaceuticals
AMLX
$2B
$11.5M 0.76%
950,000
-500,000
KYMR icon
38
Kymera Therapeutics
KYMR
$7.21B
$10.1M 0.67%
130,000
-120,000
CLDX icon
39
Celldex Therapeutics
CLDX
$2.71B
$9.51M 0.63%
+350,000
NRIX icon
40
Nurix Therapeutics
NRIX
$1.78B
$9.48M 0.63%
+500,000
CGON icon
41
CG Oncology
CGON
$5.66B
$8.3M 0.55%
+200,000
ACLX icon
42
Arcellx
ACLX
$6.73B
$7.5M 0.5%
115,000
-50,000
CBIO
43
Crescent Biopharma
CBIO
$601M
$7.12M 0.47%
600,000
CMPX icon
44
Compass Therapeutics
CMPX
$1.2B
$6.18M 0.41%
1,150,000
-900,000
JBIO
45
Jade Biosciences
JBIO
$1.08B
$6.09M 0.41%
395,000
-230,000
TYRA icon
46
Tyra Biosciences
TYRA
$1.9B
$5.52M 0.37%
+210,000
ELVN icon
47
Enliven Therapeutics
ELVN
$2.82B
$5.24M 0.35%
340,000
IMMX icon
48
Immix Biopharma
IMMX
$527M
$5.23M 0.35%
+1,000,000
CNTA
49
Centessa Pharmaceuticals
CNTA
$6.11B
$5M 0.33%
200,000
-325,000
NGNE icon
50
Neurogene
NGNE
$433M
$4.02M 0.27%
+195,000
1
2
3 4